HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation

Journal of Molecular Biology

Volumn 410, Issue 4, 2011, Pages 582-608

  Checkley, Mary Ann ^a   Luttge, Benjamin G ^a   Freed, Eric O ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Assembly; Envelope glycoprotein; HIV 1; Retrovirus; Trafficking

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE;

CELL SURFACE; GLYCOPROTEIN SYNTHESIS; LIPID BILAYER; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VIRION; VIRUS ASSEMBLY; VIRUS PARTICLE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80051737642     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.04.042     Document Type: Review

References (307)

1. Berger, E. A., Murphy, P. M. & Farber, J. M. (1999). Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700. (Pubitemid 29241137)
2. Daecke, J., Fackler, O. T., Dittmar, M. T. & Kräusslich, H.-G. (2005). Involvement of clathrin-mediated en-docytosis in human immunodeficiency virus type 1 entry. J. Virol. 79, 1581-1594. (Pubitemid 40459105)
3. Miyauchi, K., Kim, Y., Latinovic, O., Morozov, V. & Melikyan, G. B. (2009). HIV enters cells via endocy-tosis and dynamin-dependent fusion with endo-somes. Cell, 137, 433-444.
4. Berger, E. A., Doms, R. W., Fenyö, E. M., Korber, B. T., Littman, D. R., Moore, J. P. et al. (1998). A new classification for HIV-1. Nature, 391, 240.
5. Gorry, P. R. & Ancuta, P. (2011). Coreceptors and HIV-1 pathogenesis. Curr. HIV/AIDS Rep. 8, 45-53.
6. Goff, S. P. (2001). Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways. J. Gene Med. 3, 517-528. (Pubitemid 33685083)
7. Suzuki, Y. & Craigie, R. (2007). The road to chromatin-nuclear entry of retroviruses. Nat. Rev., Microbiol. 5, 187-196.
8. Fassati, A. & Goff, S. P. (2001). Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75, 3626-3635. (Pubitemid 32246372)
9. Bukrinsky, M., Sharova, N., Dempsey,M.P., Stanwick, T. L., Bukrinskaya, A. G., Haggerty, S. & Stevenson, M. (1992). Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl Acad. Sci. USA, 89, 6580-6584.
10. Whittaker, G. R., Kann, M. & Helenius, A. (2000). Viral entry into the nucleus. Annu. Rev. Cell Dev. Biol. 16, 627-651. (Pubitemid 32037519)
11. Freed, E. O. & Martin, M. A. (2006). HIVs and their replication. In Fields Virology (Knipe, D. M., Howley, P. M., Griffin, D. E., Lamb, R. A., Martin, M. A., Roizman, B. & Straus, S. E., eds), 5th edit. Lippincott Williams & Wilkins, Philadelphia, PA.
12. Swanstrom, R. & Wills, J. W. (1997). Synthesis, assembly, and processing of viral proteins. In Retro-viruses (Coffin, J. M., Hughes, S. H. & Varmus, H. E., eds), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. Freed, E. O. (1998). HIV-1 gag proteins: diverse functions in the virus life cycle. Virology, 251, 1-15. (Pubitemid 28527713)
14. Adamson, C. S. & Freed, E. O. (2007). Human immunodeficiency virus type 1 assembly, release, and maturation. Adv. Pharmacol. 55, 347-387.
15. Bieniasz, P. D. (2009). The cell biology of HIV-1 virion genesis. Cell Host Microbe, 5, 550-558.
16. Zhou, W., Parent, L. J., Wills, J. W. & Resh, M. D. (1994). Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68, 2556-2569.
17. Massiah, M. A., Starich, M. R., Paschall, C, Summers, M. F., Christensen, A. M. & Sundquist, W. I. (1994). Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 244, 198-223. (Pubitemid 24366038)
18. Hill, C. P., Worthylake, D., Bancroft, D. P., Christensen, A. M. & Sundquist, W. I. (1996). Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl Acad. Sci. USA, 93, 3099-3104. (Pubitemid 26114370)
19. Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K. & Freed, E. O. (2004). Phosphatidylinositol (4,5) bispho-sphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl Acad. Sci. USA, 101, 14889-14894. (Pubitemid 39410770)
20. Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H. & Summers, M. F. (2006). Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl Acad. Sci. USA, 103, 11364-11369. (Pubitemid 44156523)
21. Demirov, D. G. & Freed, E. O. (2004). Retrovirus budding. Virus Res. 106, 87-102. (Pubitemid 39582739)
22. Morita, E. & Sundquist, W. I. (2004). Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20, 395-425. (Pubitemid 39488644)
23. Bieniasz, P. D. (2006). Late budding domains and host proteins in enveloped virus release. Virology, 344, 55-63. (Pubitemid 41814450)
24. Fujii, K., Hurley, J. H. & Freed, E. O. (2007). Beyond Tsg101: the role of Alix in ESCRTing' HIV-1. Nat. Rev., Microbiol. 5, 912-916. (Pubitemid 350131179)
25. Hurley, J. H, Boura, E., Carlson, L.-A. & Rózycki, B. (2010). Membrane budding. Cell, 143, 875-887.
26. Jouvenet, N., Neil, S. J. D., Bess, C, Johnson, M. C, Virgen, C. A., Simon, S. M. & Bieniasz, P. D. (2006). Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4, e435.
27. Balasubramaniam, M. & Freed, E. O. (2011). New insights into HIV assembly and trafficking. Physiology, in press.
28. Welsch, S., Keppler, O. T., Habermann, A., Allespach, I., Krijnse-Locker, J. & Kräusslich, H.-G. (2007). HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 3, e36.
29. Finzi, A., Orthwein, A., Mercier, J. & Cohen, E. A. (2007). Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J. Virol. 81, 7476-7490. (Pubitemid 47047835)
30. Joshi, A., Ablan, S. D., Soheilian, F., Nagashima, K. & Freed, E. O. (2009). Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment. J. Virol. 83, 5375-5387.
31. Deneka, M., Pelchen-Matthews, A., Byland, R., Ruiz-Mateos, E. & Marsh, M. (2007). In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 177, 329-341. (Pubitemid 46658643)
32. Bennett, A. E., Narayan, K., Shi, D., Hartnell, L. M., Gousset, K., He, H. et al. (2009). Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macro-phages. PLoS Pathog. 5, e1000591.
33. Gousset, K., Ablan, S. D., Coren, L. V., Ono, A., Soheilian, F., Nagashima, K. et al. (2008). Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 4, e1000015.
34. Ono, A. & Freed, E. O. (2005). Role of lipid rafts in virus replication. Adv. Virus Res. 64, 311-358.
35. Hunter, E. & Swanstrom, R. (1990). Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157, 187-253.
36. Freed, E. O. & Martin, M. A. (1995). The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 270, 23883-23886.
37. Haffar, O., Dowbenko, D. J. & Berman, P. W. (1988). Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes. J. Cell Biol. 107, 1677-1687. (Pubitemid 18263541)
38. Berman, P. W., Nunes, W. M. & Haffar, O. (1988). Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines. J. Virol. 62, 3135-3142.
39. Allan, J. S., Coligan, J. E., Barin, F., McLane, M. F., Sodroski, J. G., Rosen, C. A. et al. (1985). Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science, 228, 1091-1094. (Pubitemid 15227368)
40. Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N. & Gregory, T. J. (1990). Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265, 10373-10382.
41. Bernstein, H. B., Tucker, S. P., Hunter, E., Schutzbach, J. S. & Compans, R. W. (1994). Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J. Virol. 68, 463-468.
42. Pinter, A., Honnen, W. J., Tilley, S. A., Bona, C., Zaghouani, H., Gorny, M. K. & Zolla-Pazner, S. (1989). Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 63, 2674-2679. (Pubitemid 19137546)
43. Schawaller, M., Smith, G. E., Skehel, J. J. & Wiley, D. C. (1989). Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology, 172, 367-369. (Pubitemid 19221465)
44. Earl, P. L., Doms, R. W. & Moss, B. (1990). Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl Acad. Sci. USA, 87, 648-652.
45. Earl, P. L., Koenig, S. & Moss, B. (1991). Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65, 31-41.
46. Fujita, K., Omura, S. & Silver, J. (1997). Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J. Gen. Virol. 78, 619-625. (Pubitemid 27116783)
47. Schubert, U., Antón, L. C., Bacík, I., Cox, J. H., Bour, S., Bennink, J. R. et al. (1998). CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72, 2280-2288. (Pubitemid 28100787)
48. Margottin, F., Bour, S. P., Durand, H., Selig, L., Benichou, S., Richard, V. et al. (1998). A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell, 1, 565-574. (Pubitemid 128374692)
49. Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H. D. & Garten, W. (1992). Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature, 360, 358-361. (Pubitemid 23000676)
50. McCune,J.M., Rabin,L.B., Feinberg,M.B., Lieberman, M., Kosek, J. C., Reyes, G. R. & Weissman, I. L. (1988). Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell, 53, 55-67.
51. Freed, E. O., Myers, D. J. & Risser, R. (1989). Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. J. Virol. 63, 4670-4675. (Pubitemid 19257842)
52. Rowell, J. F., Ruff, A. L., Guarnieri, F. G., Staveley-O'Carroll, K., Lin, X., Tang, J. et al. (1995). Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells. J. Immunol. 155, 1818-1828.
53. Egan, M. A., Carruth, L. M., Rowell, J. F., Yu, X. & Siliciano, R. F. (1996). Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J. Virol. 70, 6547-6556. (Pubitemid 26307359)
54. Zhu, P., Chertova, E., Bess, J., Lifson, J. D., Arthur, L. O., Liu, J. et al. (2003). Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl Acad. Sci. USA, 100, 15812-15817. (Pubitemid 38021072)
55. Jolly, C. & Sattentau, Q. J. (2004). Retroviral spread by induction of virological synapses. Traffic, 5, 643-650. (Pubitemid 39199128)
56. McDonald, D., Wu, L., Bohks, S. M., KewalRamani, V. N., Unutmaz, D. & Hope, T. J. (2003). Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science, 300, 1295-1297. (Pubitemid 36618241)
57. Sattentau, Q. J. (2010). Cell-to-cell spread of retrovi-ruses. Viruses, 2, 1306-1321.
58. Jolly, C. (2010). T cell polarization at the virological synapse. Viruses, 2, 1261-1278.
59. Mothes, W., Sherer, N. M., Jin, J. & Zhong, P. (2010). Virus cell-to-cell transmission. J. Virol. 84, 8360-8368.
60. Dimitrov, D. S., Willey, R. L., Sato, H., Chang, L. J., Blumenthal, R. & Martin, M. A. (1993). Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67, 2182-2190. (Pubitemid 23088394)
61. Jolly, C., Kashefi, K., Hollinshead, M. & Sattentau, Q. J. (2004). HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 199, 283-293. (Pubitemid 38129707)
62. Jolly, C., Mitar, I. & Sattentau, Q. J. (2007). Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells. J. Virol. 81, 13916-13921. (Pubitemid 350247884)
63. Jolly, C., Mitar, I. & Sattentau, Q. J. (2007). Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J. Virol. 81, 5547-5560. (Pubitemid 46846995)
64. Jolly, C. & Sattentau, Q. J. (2007). Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J. Virol. 81, 7873-7884. (Pubitemid 47101473)
65. Sherer, N. M., Lehmann, M. J., Jimenez-Soto, L. F., Horensavitz, C., Pypaert, M. & Mothes, W. (2007). Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat. Cell Biol. 9, 310-315. (Pubitemid 46344610)
66. Sherer, N. M., Jin, J. & Mothes, W. (2010). Directional spread of surface-associated retroviruses regulated by differential virus-cell interactions. J. Virol. 84, 3248-3258.
67. Jin, J., Sherer, N. M., Heidecker, G., Derse, D. & Mothes, W. (2009). Assembly of the murine leukemia virus is directed towards sites of cell-cell contact. PLoS Biol. 7, e1000163.
68. Waki, K. & Freed, E. O. (2010). Macrophages and cell-cell spread of HIV-1. Viruses, 2, 1603-1620.
69. Starcich, B. R., Hahn, B. H., Shaw, G. M., McNeely, P. D., Modrow, S., Wolf, H. et al. (1986). Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell, 45, 637-648. (Pubitemid 16063128)
70. Willey, R. L., Rutledge, R. A., Dias, S., Folks, T., Theodore, T., Buckler, C. E. & Martin, M. A. (1986). Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc. Natl Acad. Sci. USA, 83, 5038-5042. (Pubitemid 16051313)
71. Gao, F., Morrison, S. G., Robertson, D. L., Thornton, C. L., Craig, S., Karlsson, G. et al. (1996). Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization. J. Virol. 70, 1651-1667. (Pubitemid 26062925)
72. Jobes, D. V., Daoust, M., Nguyen, V., Padua, A., Michele, S., Lock, M. D. et al. (2006). High incidence of unusual cysteine variants in gp120 envelope proteins from early HIV type 1 infections from a Phase 3 vaccine efficacy trial. AIDS Res. Hum. Retroviruses, 22, 1014-1021. (Pubitemid 46100687)
73. Montefiori, D. C., Robinson, W. E. & Mitchell, W. M. (1988). Role of protein N-glycosylation in pathogen-esis of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA, 85, 9248-9252. (Pubitemid 19001874)
74. Li, H., Chien, P. C., Tuen, M., Visciano, M. L., Cohen, S., Blais, S. et al. (2008). Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopes. J. Immunol. 180, 4011-4021.
75. Raska, M. & Novak, J. (2010). Involvement of envelope-glycoprotein glycans in HIV-1 biology and infection. Arch. Immunol. Ther. Exp. (Warsz), 58, 191-208.
76. Palmer, C., Balfe, P., Fox, D., May, J. C., Frederiksson, R., Fenyö, E. M. & McKeating, J. A. (1996). Functional characterization of the V1V2 region of human immunodeficiency virus type 1. Virology, 220, 436-449. (Pubitemid 26201698)
77. Masciotra, S., Owen, S. M., Rudolph, D., Yang, C., Wang, B., Saksena, N. et al. (2002). Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression. AIDS, 16, 1887-1898.
78. Shioda, T., Oka, S., Xin, X., Liu, H., Harukuni, R., Kurotani, A. et al. (1997). In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression. J. Virol. 71, 4871-4881. (Pubitemid 27258154)
79. Chohan, B., Lang, D., Sagar, M., Korber, B., Lavreys, L., Richardson, B. & Overbaugh, J. (2005). Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J. Virol. 79, 6528-6531. (Pubitemid 40617257)
80. Sagar, M., Wu, X., Lee, S. & Overbaugh, J. (2006). Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosyl-ation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J. Virol. 80, 9586-9598. (Pubitemid 44435633)
81. Kitrinos, K. M., Hoffman, N. G., Nelson, J. A. E. & Swanstrom, R. (2003). Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection. J. Virol. 77, 6811-6822. (Pubitemid 36666875)
82. Curlin, M. E., Zioni, R., Hawes, S. E., Liu, Y., Deng, W., Gottlieb, G. S. et al. (2010). HIV-1 envelope subregion length variation during disease progression. PLoS Pathog. 6, e1001228.
83. Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E. et al. (1987). Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell, 50, 975-985.
84. Kowalski, M., Potz, J., Basiripour, L., Dorfman, T., Goh, W. C., Terwilliger, E. et al. (1987). Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science, 237, 1351-1355. (Pubitemid 17134619)
85. Olshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W. & Sodroski, J. (1990). Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64, 5701-5707.
86. Pollard, S. R., Rosa, M. D., Rosa, J. J. & Wiley, D. C. (1992). Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. EMBO J. 11, 585-591.
87. Wyatt, R., Sullivan, N., Thali, M., Repke, H., Ho, D., Robinson, J. et al. (1993). Functional and immuno-logic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67, 4557-4565. (Pubitemid 23215934)
88. Freed, E. O., Myers, D. J. & Risser, R. (1991). Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J. Virol. 65, 190-194.
89. O'Brien, W. A., Koyanagi, Y., Namazie, A., Zhao, J. Q., Diagne, A., Idler, K. et al. (1990). HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature, 348, 69-73.
90. Hwang, S. S., Boyle, T. J., Lyerly, H. K. & Cullen, B. R. (1991). Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science, 253, 71-74. (Pubitemid 21917121)
91. Shioda, T., Levy, J. A. & Cheng-Mayer, C. (1991). Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature, 349, 167-169. (Pubitemid 21912038)
92. Chesebro, B., Nishio, J., Perryman, S., Cann, A., O'Brien, W., Chen, I. S. & Wehrly, K. (1991). Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J. Virol. 65, 5782-5789.
93. Cann, A. J., Churcher, M. J., Boyd, M., O'Brien, W., Zhao, J. Q., Zack, J. & Chen, I. S. (1992). The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J. Virol. 66, 305-309.
94. Rusche, J. R., Javaherian, K., McDanal, C., Petro, J., Lynn, D. L., Grimaila, R. et al. (1988). Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl Acad. Sci. USA, 85, 3198-3202.
95. Palker, T. J., Clark, M. E., Langlois, A. J., Matthews, T. J., Weinhold, K. J., Randall, R. R. et al. (1988). Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl Acad. Sci. USA, 85, 1932-1936. (Pubitemid 24315798)
96. Goudsmit, J., Debouck, C., Meloen, R. H., Smit, L., Bakker, M., Asher, D. M. et al. (1988). Human immunodeficiency virus type 1 neutralization epi-tope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl Acad. Sci. USA, 85, 4478-4482.
97. Matsushita, S., Robert-Guroff, M., Rusche, J., Koito, A., Hattori, T., Hoshino, H. et al. (1988). Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62, 2107-2114.
98. Shioda, T., Oka, S., Ida, S., Nokihara, K., Toriyoshi, H., Mori, S. et al. (1994). A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. J. Virol. 68, 7689-7696. (Pubitemid 24362654)
99. Fouchier, R. A., Groenink, M., Kootstra, N. A., Tersmette, M., Huisman, H. G., Miedema, F. & Schuitemaker, H. (1992). Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66, 3183-3187.
100. Pollakis, G., Abebe, A., Kliphuis, A., Chalaby, M. I.M., Bakker, M., Mengistu, Y. et al. (2004). Phenotypic and genotypic comparisons of CCR5-and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals. J. Virol. 78, 2841-2852. (Pubitemid 38314342)
101. Rizzuto, C. D., Wyatt, R., Hernández-Ramos, N., Sun, Y., Kwong, P. D., Hendrickson, W. A. & Sodroski, J. (1998). A conserved HIV gp120 glyco-protein structure involved in chemokine receptor binding. Science, 280, 1949-1953. (Pubitemid 28299405)
102. Rizzuto, C. & Sodroski, J. (2000). Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120. AIDS Res. Hum. Retroviruses, 16, 741-749. (Pubitemid 30327291)
103. Cormier, E. G., Tran, D. N., Yukhayeva, L., Olson, W. C. & Dragic, T. (2001). Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes. J. Virol. 75, 5541-5549. (Pubitemid 32488147)
104. Cormier, E. G. & Dragic, T. (2002). The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycopro-tein interactions with the CCR5 coreceptor. J. Virol. 76, 8953-8957. (Pubitemid 34864089)
105. Dragic, T., Trkola, A., Thompson, D. A., Cormier, E. G., Kajumo, F. A., Maxwell, E. et al. (2000). A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl Acad. Sci. USA, 97, 5639-5644. (Pubitemid 30313771)
106. Westby, M., Smith-Burchnell, C., Mori, J., Lewis, M., Mosley, M., Stockdale, M. et al. (2007). Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry. J. Virol. 81, 2359-2371.
107. Pugach, P., Marozsan, A. J., Ketas, T. J., Landes, E. L., Moore, J. P. & Kuhmann, S. E. (2007). HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry. Virology, 361, 212-228. (Pubitemid 46551222)
108. Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J. & Hendrickson, W. A. (1998). Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature, 393, 648-659. (Pubitemid 28289647)
109. Chen, B., Vogan, E. M., Gong, H., Skehel, J. J., Wiley, D. C. & Harrison, S. C. (2005). Structure of an unliganded simian immunodeficiency virus gp120 core. Nature, 433, 834-841. (Pubitemid 40314887)
110. Wu, S.-R., Löving, R., Lindqvist, B., Hebert, H., Koeck, P. J. B., Sjöberg, M. & Garoff, H. (2010). Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure. Proc. Natl. Acad. Sci. USA, 107, 18844-18849
111. Huang, C.-c., Tang, M., Zhang, M.-Y., Majeed, S., Montabana, E., Stanfield, R. L. et al. (2005). Structure of a V3-containing HIV-1 gp120 core. Science, 310, 1025-1028. (Pubitemid 41611916)
112. Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H. et al. (2007). Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature, 445, 732-737. (Pubitemid 46279718)
113. Chen, L., Kwon, Y. D., Zhou, T., Wu, X., O'Dell, S., Cavacini, L. et al. (2009). Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science, 326, 1123-1127.
114. Pancera, M., Majeed, S., Ban, Y.-E. A., Chen, L., Huang, C.-c., Kong, L. et al. (2010). Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility. Proc. Natl Acad. Sci. USA, 107, 1166-1171.
115. Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G. & Subramaniam, S. (2008). Molecular architecture of native HIV-1 gp120 trimers. Nature, 455, 109-113.
116. Cordonnier, A., Montagnier, L. & Emerman, M. (1989). Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature, 340, 571-574. (Pubitemid 19201701)
117. Bosch, M. L., Earl, P. L., Fargnoli, K., Picciafuoco, S., Giombini, F., Wong-Staal, F. & Franchini, G. (1989). Identification of the fusion peptide of primate immunodeficiency viruses. Science, 244, 694-697. (Pubitemid 19147680)
118. Freed, E. O., Myers, D. J. & Risser, R. (1990). Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl Acad. Sci. USA, 87, 4650-4654.
119. Freed, E. O., Delwart, E. L., Buchschacher, G. L. & Panganiban, A. T. (1992). A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl Acad. Sci. USA, 89, 70-74.
120. Chan, D. C., Fass, D., Berger, J. M. & Kim, P. S. (1997). Core structure of gp41 from the HIV envelope glycoprotein. Cell, 89, 263-273. (Pubitemid 27199898)
121. Dubay, J. W., Roberts, S. J., Brody, B. & Hunter, E. (1992). Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66, 4748-4756.
122. Lu, M., Blacklow, S. C. & Kim, P. S. (1995). A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2, 1075-1082.
123. Tan, K., Liu, J., Wang, J., Shen, S. & Lu, M. (1997). Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl Acad. Sci. USA, 94, 12303-12308. (Pubitemid 27492523)
124. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J. & Wiley, D. C. (1997). Atomic structure of the ectodomain from HIV-1 gp41. Nature, 387, 426-430. (Pubitemid 27227210)
125. Muñoz-Barroso, I., Salzwedel, K., Hunter, E. & Blumenthal, R. (1999). Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycopro-tein-mediated membrane fusion. J. Virol. 73, 6089-6092. (Pubitemid 29274898)
126. Salzwedel, K., West, J. T. & Hunter, E. (1999). A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J. Virol. 73, 2469-2480. (Pubitemid 29098154)
127. Brasseur, R., Vandenbranden, M., Cornet, B., Burny, A. & Ruysschaert, J. M. (1990). Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins. Biochim. Biophys. Acta, 1029, 267-273. (Pubitemid 20372063)
128. White, J. M., Delos, S. E., Brecher, M. & Schornberg, K. (2008). Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43, 189-219. (Pubitemid 351883153)
129. Südhof, T. C. & Rothman, J. E. (2009). Membrane fusion: grappling with SNARE and SM proteins. Science, 323, 474-477.
130. Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B. & Matthews, T. J. (1994). Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl Acad. Sci. USA, 91, 9770-9774. (Pubitemid 24311889)
131. Furuta, R. A., Wild, C. T., Weng, Y. & Weiss, C. D. (1998). Capture of an early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol. 5, 276-279. (Pubitemid 28164878)
132. Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y. et al. (1998). Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4, 1302-1307. (Pubitemid 28512112)
133. LaBonte, J., Lebbos, J. & Kirkpatrick, P. (2003). Enfuvirtide. Nat. Rev., Drug Discov. 2, 345-346. (Pubitemid 37361704)
134. Poumbourios, P., el Ahmar, W., McPhee, D. A. & Kemp, B. E. (1995). Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J. Virol. 69, 1209-1218.
135. Cao, J., Bergeron, L., Helseth, E., Thali, M., Repke, H. & Sodroski, J. (1993). Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67, 2747-2755. (Pubitemid 23118873)
136. Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M. et al. (2001). Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75, 10892-10905. (Pubitemid 33034579)
137. Shang, L., Yue, L. & Hunter, E. (2008). Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection. J. Virol. 82, 5417-5428. (Pubitemid 351705249)
138. Shang, L. & Hunter, E. (2010). Residues in the membrane-spanning domain core modulate conformation and fusogenicity of the HIV-1 envelope glycoprotein. Virology, 404, 158-167.
139. Kondo, N., Miyauchi, K., Meng, F., Iwamoto, A. & Matsuda, Z. (2010). Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain. J. Biol. Chem. 285, 14681-14688.
140. Waheed, A. A., Ablan, S. D., Mankowski, M. K., Cummins, J. E., Ptak, R. G., Schaffner, C. P. & Freed, E. O. (2006). Inhibition of HIV-1 replication by amphotericin B methyl ester: selection for resistant variants. J. Biol. Chem. 281, 28699-28711. (Pubitemid 44507012)
141. Waheed, A. A., Ablan, S. D., Roser, J. D., Sowder, R. C., Schaffner, C. P., Chertova, E. & Freed, E. O. (2007). HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease. Proc. Natl Acad. Sci. USA, 104, 8467-8471. (Pubitemid 47175511)
142. Waheed, A. A., Ablan, S. D., Sowder, R. C., Roser, J. D., Schaffner, C. P., Chertova, E. & Freed, E. O. (2010). Effect of mutations in the human immunodeficiency virus type 1 protease on cleavage of the gp41 cytoplasmic tail. J. Virol. 84, 3121-3126.
143. Steckbeck, J. D., Sun, C., Sturgeon, T. J. & Montelaro, R. C. (2010). Topology of the C-terminal tail of HIV-1 gp41: differential exposure of the Kennedy epitope on cell and viral membranes. PLoS ONE, 5, e15261.
144. Kennedy, R. C., Henkel, R. D., Pauletti, D., Allan, J. S., Lee, T. H., Essex, M. & Dreesman, G. R. (1986). Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science, 231, 1556-1559. (Pubitemid 16050724)
145. Chanh, T. C., Dreesman, G. R., Kanda, P., Linette, G. P., Sparrow, J. T., Ho, D. D. & Kennedy, R. C. (1986). Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J. 5, 3065-3071.
146. Cleveland, S. M., McLain, L., Cheung, L., Jones, T. D., Hollier, M. & Dimmock, N. J. (2003). A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion. J. Gen. Virol. 84, 591-602. (Pubitemid 36267132)
147. Hollier, M. J. & Dimmock, N. J. (2005). The C-terminal tail of the gp41 transmembrane envelope glycopro-tein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function. Virology, 337, 284-296. (Pubitemid 40798996)
148. Lu, L., Zhu, Y., Huang, J., Chen, X., Yang, H., Jiang, S. & Chen, Y.-H. (2008). Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: interaction with gp41 fusion core. J. Biol. Chem. 283, 16723-16731.
149. Rushlow, K., Olsen, K., Stiegler, G., Payne, S. L., Montelaro, R. C. & Issel, C. J. (1986). Lentivirus genomic organization: the complete nucleotide sequence of the env gene region of equine infectious anemia virus. Virology, 155, 309-321. (Pubitemid 17226238)
150. Rice, N. R., Henderson, L. E., Sowder, R. C., Copeland, T. D., Oroszlan, S. & Edwards, J. F. (1990). Synthesis and processing of the transmem-brane envelope protein of equine infectious anemia virus. J. Virol. 64, 3770-3778. (Pubitemid 20227201)
151. Shacklett, B. L., Weber, C. J., Shaw, K. E., Keddie, E. M., Gardner, M. B., Sonigo, P. & Luciw, P. A. (2000). The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques. J. Virol. 74, 5836-5844. (Pubitemid 30412951)
152. Lee, S. J., Hu, W., Fisher, A. G., Looney, D. J., Kao, V. F., Mitsuya, H. et al. (1989). Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity. AIDS Res. Hum. Retroviruses, 5, 441-449. (Pubitemid 19209801)
153. Wilk, T., Pfeiffer, T. & Bosch, V. (1992). Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology, 189, 167-177.
154. Gabuzda, D. H., Lever, A., Terwilliger, E. & Sodroski, J. (1992). Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66, 3306-3315.
155. Yu, X., Yuan, X., McLane, M. F., Lee, T. H. & Essex, M. (1993). Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmem-brane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67, 213-221. (Pubitemid 23002981)
156. Wyss, S., Berlioz-Torrent, C., Boge, M., Blot, G., Höning, S., Benarous, R. & Thali, M. (2001). The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter]. J. Virol. 75, 2982-2992. (Pubitemid 32185063)
157. Freed, E. O. & Martin, M. A. (1995). Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69, 1984-1989.
158. Freed, E. O. & Martin, M. A. (1996). Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70, 341-351. (Pubitemid 126508804)
159. Murakami, T. & Freed, E. O. (2000). The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc. Natl Acad. Sci. USA, 97, 343-348. (Pubitemid 30055833)
160. Murakami, T. & Freed, E. O. (2000). Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail. J. Virol. 74, 3548-3554. (Pubitemid 30180297)
161. Kalia, V., Sarkar, S., Gupta, P. & Montelaro, R. C. (2003). Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation. J. Virol. 77, 3634-3646. (Pubitemid 36297283)
162. Affranchino, J. L. & González, S. A. (2006). Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions. Virology, 347, 217-225.
163. Spies, C. P., Ritter, G. D., Mulligan, M. J. & Compans, R. W. (1994). Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J. Virol. 68, 585-591. (Pubitemid 24022156)
164. Edwards, T. G., Wyss, S., Reeves, J. D., Zolla-Pazner, S., Hoxie, J. A., Doms, R. W. & Baribaud, F. (2002). Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein. J. Virol. 76, 2683-2691. (Pubitemid 34184854)
165. Kalia, V., Sarkar, S., Gupta, P. & Montelaro, R. C. (2005). Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41. J. Virol. 79, 2097-2107. (Pubitemid 40204567)
166. Vzorov, A. N., Gernert, K. M. & Compans, R. W. (2005). Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity. Virology, 332, 89-101. (Pubitemid 40127232)
167. Edwards, T. G., Hoffman, T. L., Baribaud, F., Wyss, S., LaBranche, C. C., Romano, J. et al. (2001). Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J. Virol. 75, 5230-5239. (Pubitemid 32448546)
168. Rowell, J. F., Stanhope, P. E. & Siliciano, R. F. (1995). Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J. Immunol. 155, 473-488.
169. Ohno, H., Aguilar, R. C., Fournier, M. C., Hennecke, S., Cosson, P. & Bonifacino, J. S. (1997). Interaction of endocytic signals from the HIV-1 envelope glyco-protein complex with members of the adaptor medium chain family. Virology, 238, 305-315. (Pubitemid 28218148)
170. Boge, M., Wyss, S., Bonifacino, J. S. & Thali, M. (1998). A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor. J. Biol. Chem. 273, 15773-15778. (Pubitemid 28298198)
171. Berlioz-Torrent, C., Shacklett, B. L., Erdtmann, L., Delamarre, L., Bouchaert, I., Sonigo, P. et al. (1999). Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins. J. Virol. 73, 1350-1361. (Pubitemid 29036790)
172. Lodge, R., Lalonde, J. P., Lemay, G. & Cohen, E. A. (1997). The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J. 16, 695-705. (Pubitemid 27089517)
173. Deschambeault, J., Lalonde, J. P., Cervantes-Acosta, G., Lodge, R., Cohen, E. A. & Lemay, G. (1999). Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission. J. Virol. 73, 5010-5017. (Pubitemid 29246762)
174. Day, J. R., Münk, C. & Guatelli, J. C. (2004). The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity. J. Virol. 78, 1069-1079. (Pubitemid 38095817)
175. West, J. T., Weldon, S. K., Wyss, S., Lin, X., Yu, Q., Thali, M. & Hunter, E. (2002). Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation. J. Virol. 76, 3338-3349. (Pubitemid 34224536)
176. Fultz, P. N., Vance, P. J., Endres, M. J., Tao, B., Dvorin, J. D., Davis, I. C. et al. (2001). In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail. J. Virol. 75, 278-291.
177. Byland, R., Vance, P. J., Hoxie, J. A. & Marsh, M. (2007). A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein. Mol. Biol. Cell, 18, 414-425. (Pubitemid 46213212)
178. Miller, M. A., Garry, R. F., Jaynes, J. M. & Montelaro, R. C. (1991). A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res. Hum. Retroviruses, 7, 511-519.
179. Miller, M. A., Cloyd, M. W., Liebmann, J., Rinaldo, C. R., Islam, K. R., Wang, S. Z. et al. (1993). Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmem-brane protein. Virology, 196, 89-100.
180. Eisenberg, D. & Wesson, M. (1990). The most highly amphiphilic alpha-helices include two amino acid segments in human immunodeficiency virus glyco-protein 41. Biopolymers, 29, 171-177. (Pubitemid 20055813)
181. Venable, R. M., Pastor, R. W., Brooks, B. R. & Carson, F. W. (1989). Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein. AIDS Res. Hum. Retroviruses, 5, 7-22. (Pubitemid 19079107)
182. Lee, S. F., Ko, C. Y., Wang, C. T. & Chen, S. S.L. (2002). Effect of point mutations in the N terminus of the lentivirus lytic peptide-1 sequence of human immunodeficiency virus type 1 transmembrane protein gp41 on Env stability. J. Biol. Chem. 277, 15363-15375.
183. Lee, S. F., Wang, C. T., Liang, J. Y., Hong, S. L., Huang, C. C. & Chen, S. S. (2000). Multimerization potential of the cytoplasmic domain of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41. J. Biol. Chem. 275, 15809-15819. (Pubitemid 30366880)
184. Bültmann, A., Muranyi, W., Seed, B. & Haas, J. (2001). Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression. J. Virol. 75, 5263-5276. (Pubitemid 32448549)
185. Cosson, P. (1996). Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15, 5783-5788. (Pubitemid 26375499)
186. Piller, S. C., Dubay, J. W., Derdeyn, C. A. & Hunter, E. (2000). Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycopro-tein incorporation and infectivity. J. Virol. 74, 11717-11723. (Pubitemid 32222321)
187. Chen, S. S., Lee, S. F. & Wang, C. T. (2001). Cellular membrane-binding ability of the C-terminal cyto-plasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41. J. Virol. 75, 9925-9938. (Pubitemid 32900127)
188. Chernomordik, L., Chanturiya, A. N., Suss-Toby, E., Nora, E. & Zimmerberg, J. (1994). An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 68, 7115-7123. (Pubitemid 24328763)
189. Gawrisch, K., Han, K. H., Yang, J. S., Bergelson, L. D. & Ferretti, J. A. (1993). Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type I with lipid bilayers. Biochemistry, 32, 3112-3118. (Pubitemid 23110155)
190. Comardelle, A. M., Norris, C. H., Plymale, D. R., Gatti, P. J., Choi, B., Fermin, C. D. et al. (1997). A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes. AIDS Res. Hum. Retroviruses, 13, 1525-1532. (Pubitemid 27500582)
191. Tencza, S. B., Miller, M. A., Islam, K., Mietzner, T. A. & Montelaro, R. C. (1995). Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein. J. Virol. 69, 5199-5202.
192. Rousso, I., Mixon, M. B., Chen, B. K. & Kim, P. S. (2000). Palmitoylation of the HIV-1 envelope glyco-protein is critical for viral infectivity. Proc. Natl Acad. Sci. USA, 97, 13523-13525.
193. Yang, P., Ai, L.-S., Huang, S.-C., Li, H.-F., Chan, W.-E., Chang, C.-W. et al. (2010). The cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 harbors lipid raft association determinants. J. Virol. 84, 59-75.
194. Fuller, S. D., Berriman, J. A., Butcher, S. J. & Gowen, B. E. (1995). Low pH induces swiveling of the glycoprotein heterodimers in the Semliki Forest virus spike complex. Cell, 81, 715-725.
195. Garoff, H., Sjöberg, M. & Cheng, R. H. (2004). Budding of alphaviruses. Virus Res. 106, 103-116. (Pubitemid 39572959)
196. Lusso, P., di Marzo Veronese, F., Ensoli, B., Franchini, G., Jemma, C., DeRocco, S. E. et al. (1990). Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science, 247, 848-852.
197. Arthur, L. O., Bess, J. W., Sowder, R. C., Benveniste, R. E., Mann, D. L., Chermann, J. C. & Henderson, L. E. (1992). Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science, 258, 1935-1938. (Pubitemid 23026732)
198. Ott, D. E. (2008). Cellular proteins detected in HIV-1. Rev. Med. Virol. 18, 159-175. (Pubitemid 351693494)
199. Page, K. A., Landau, N. R. & Littman, D. R. (1990). Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64, 5270-5276. (Pubitemid 20364514)
200. Cronin, J., Zhang, X.-Y. & Reiser, J. (2005). Altering the tropism of lentiviral vectors through pseudotyp-ing. Curr. Gene Ther. 5, 387-398. (Pubitemid 41052430)
201. Chen, S. S., Ferrante, A. A. & Terwilliger, E. F. (1996). Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity. Virology, 226, 260-268. (Pubitemid 27025806)
202. Yu, X., Yuan, X., Matsuda, Z., Lee, T. H. & Essex, M. (1992). The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66, 4966-4971.
203. Dorfman, T., Mammano, F., Haseltine, W. A. & Gottlinger, H. G. (1994). Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68, 1689-1696. (Pubitemid 24065736)
204. Mammano, F., Kondo, E., Sodroski, J., Bukovsky, A. & Gottlinger, H. G. (1995). Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69, 3824-3830.
205. Reil, H., Bukovsky, A. A., Gelderblom, H. R. & Gottlinger, H. G. (1998). Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17, 2699-2708. (Pubitemid 28221204)
206. Dubay, J. W., Roberts, S. J., Hahn, B. H. & Hunter, E. (1992). Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66, 6616-6625.
207. Iwatani, Y., Ueno, T., Nishimura, A., Zhang, X., Hattori, T., Ishimoto, A. et al. (2001). Modification of virus infectivity by cytoplasmic tail of HIV-1 TM protein. Virus Res. 74, 75-87. (Pubitemid 32168195)
208. Rao, Z., Belyaev, A. S., Fry, E., Roy, P., Jones, I. M. & Stuart, D. I. (1995). Crystal structure of SIV matrix antigen and implications for virus assembly. Nature, 378, 743-747. (Pubitemid 26001950)
209. Freed, E. O., Englund, G. & Martin, M. A. (1995). Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol. 69, 3949-3954.
210. Owens, R. J. & Compans, R. W. (1989). Expression of the human immunodeficiency virus envelope glyco-protein is restricted to basolateral surfaces of polarized epithelial cells. J. Virol. 63, 978-982. (Pubitemid 19057274)
211. Owens, R. J., Dubay, J. W., Hunter, E. & Compans, R. W. (1991). Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc. Natl Acad. Sci. USA, 88, 3987-3991. (Pubitemid 21916749)
212. Lodge, R., Gottlinger, H. G., Gabuzda, D., Cohen, E. A. & Lemay, G. (1994). The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 68, 4857-4861. (Pubitemid 24226550)
213. Wyma, D. J., Jiang, J., Shi, J., Zhou, J., Lineberger, J. E., Miller, M. D. & Aiken, C. (2004). Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplas-mic tail. J. Virol. 78, 3429-3435. (Pubitemid 38568284)
214. Murakami, T., Ablan, S. D., Freed, E. O. & Tanaka, Y. (2004). Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J. Virol. 78, 1026-1031. (Pubitemid 38067625)
215. Jiang, J. & Aiken, C. (2007). Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail. J. Virol. 81, 9999-10008. (Pubitemid 350067703)
216. Kol, N., Shi, Y., Tsvitov, M., Barlam, D., Shneck, R. Z., Kay, M. S. & Rousso, I. (2007). A stiffness switch in human immunodeficiency virus. Biophys. J. 92, 1777-1783. (Pubitemid 46393488)
217. Kiernan, R. E., Ono, A. & Freed, E. O. (1999). Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity. J. Virol. 73, 4728-4737. (Pubitemid 29246732)
218. Davis, M. R., Jiang, J., Zhou, J., Freed, E. O. & Aiken, C. (2006). A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41. J. Virol. 80, 2405-2417. (Pubitemid 43271546)
219. Hourioux, C., Brand, D., Sizaret, P. Y., Lemiale, F., Lebigot, S., Barin, F. & Roingeard, P. (2000). Identification of the glycoprotein 41(TM) cytoplas-mic tail domains of human immunodeficiency virus type 1 that interact with Pr55Gag particles. AIDS Res. Hum. Retroviruses, 16, 1141-1147. (Pubitemid 30637015)
220. Wyma, D. J., Kotov, A. & Aiken, C. (2000). Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J. Virol. 74, 9381-9387.
221. Vincent, M. J., Melsen, L. R., Martin, A. S. & Compans, R. W. (1999). Intracellular interaction of simian immunodeficiency virus Gag and Env proteins. J. Virol. 73, 8138-8144. (Pubitemid 29441674)
222. Akari, H., Fukumori, T. & Adachi, A. (2000). Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions. J. Virol. 74, 4891-4893 (Pubitemid 30237919)
223. Hirsch, V. M., Edmondson, P., Murphey-Corb, M., Arbeille, B., Johnson, P. R. & Mullins, J. I. (1989). SIV adaptation to human cells. Nature, 341, 573-574.
224. Kodama, T., Wooley, D. P., Naidu, Y. M., Kestler, H. W., Daniel, M. D., Li, Y. & Desrosiers, R. C. (1989). Significance of premature stop codons in env of simian immunodeficiency virus. J. Virol. 63, 4709-4714. (Pubitemid 19257848)
225. Luciw, P. A., Shaw, K. E., Shacklett, B. L. & Marthas, M. L. (1998). Importance of the intracytoplasmic domain of the simian immunodeficiency virus (SIV) envelope glycoprotein for pathogenesis. Virology, 252, 9-16. (Pubitemid 28564127)
226. Vzorov, A. N., Weidmann, A., Kozyr, N. L., Khaoustov, V., Yoffe, B. & Compans, R. W. (2007). Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection. Retrovirology, 4, 94.
227. Pike, L. J. (2006). Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J. Lipid Res. 47, 1597-1598. (Pubitemid 44079915)
228. Simons, K. & Gerl, M. J. (2010). Revitalizing membrane rafts: new tools and insights. Nat. Rev., Mol. Cell Biol. 11, 688-699.
229. Munro, S. (2003). Lipid rafts: elusive or illusive? Cell, 115, 377-388. (Pubitemid 37456801)
230. Waheed, A. A. & Freed, E. O. (2009). Lipids and membrane microdomains in HIV-1 replication. Virus Res. 143, 162-176.
231. Waheed, A. A. & Freed, E. O. (2010). The role of lipids in retrovirus replication. Viruses, 2, 1146-1180.
232. Brown, D. A. & Rose, J. K. (1992). Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell, 68, 533-544.
233. Brown, D. A. & London, E. (2000). Structure and function of sphingolipid-and cholesterol-rich membrane rafts. J. Biol. Chem. 275, 17221-17224. (Pubitemid 30430750)
234. Simons, K. & Toomre, D. (2000). Lipid rafts and signal transduction. Nat. Rev., Mol. Cell Biol. 1, 31-39.
235. Nguyen, D. H. & Hildreth, J. E. (2000). Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74, 3264-3272. (Pubitemid 30143751)
236. Ono, A. & Freed, E. O. (2001). Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl Acad. Sci. USA, 98, 13925-13930. (Pubitemid 33116000)
237. Pickl, W. F., Pimentel-Muiños, F. X. & Seed, B. (2001). Lipid rafts and pseudotyping. J. Virol. 75, 7175-7183. (Pubitemid 32641605)
238. Lindwasser, O. W. & Resh, M. D. (2001). Multi-merization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75, 7913-7924. (Pubitemid 32743663)
239. Holm, K., Weclewicz, K., Hewson, R.& Suomalainen, M. (2003). Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J. Virol. 77, 4805-4817. (Pubitemid 36402830)
240. Ono, A., Waheed, A. A. & Freed, E. O. (2007). Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag. Virology, 360, 27-35.
241. Waheed, A. A., Ablan, S. D., Soheilian, F., Nagashima, K., Ono, A., Schaffner, C. P. & Freed, E. O. (2008). Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence. J. Virol. 82, 9776-9781.
242. Halwani, R., Khorchid, A., Cen, S. & Kleiman, L. (2003). Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1. J. Virol. 77, 3973-3984. (Pubitemid 36350938)
243. Aloia, R. C., Tian, H. & Jensen, F. C. (1993). Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl Acad. Sci. USA, 90, 5181-5185. (Pubitemid 23183001)
244. Chan, R., Uchil, P. D., Jin, J., Shui, G., Ott, D. E., Mothes, W. & Wenk, M. R. (2008). Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 82, 11228-11238.
245. Chan, W.-E., Lin, H.-H. & Chen, S. S.-L. (2005). Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals. J. Virol. 79, 8374-8387. (Pubitemid 40853540)
246. Bhattacharya, J., Peters, P. J. & Clapham, P. R. (2004). Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cyste-ines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. J. Virol. 78, 5500-5506. (Pubitemid 38581500)
247. Bhattacharya, J., Repik, A. & Clapham, P. R. (2006). Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes. J. Virol. 80, 5292-5300.
248. Leung, K., Kim, J.-O., Ganesh, L., Kabat, J., Schwartz, O. & Nabel, G. J. (2008). HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with HIV-1 capsids and virions. Cell Host Microbe, 3, 285-292. (Pubitemid 351636000)
249. Jorgenson, R. L., Vogt, V. M. & Johnson, M. C. (2009). Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J. Virol. 83, 4060-4067.
250. Camus, G., Segura-Morales, C., Molle, D., Lopez-Vergès, S., Begon-Pescia, C., Cazevieille, C. et al. (2007). The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding. Mol. Biol. Cell, 18, 3193-3203. (Pubitemid 47235322)
251. Batonick, M., Favre, M., Boge, M., Spearman, P., Höning, S. & Thali, M. (2005). Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. Virology, 342, 190-200. (Pubitemid 41566652)
252. Díaz, E. & Pfeffer, S. R. (1998). TIP47: a cargo selection device for mannose 6-phosphate receptor trafficking. Cell, 93, 433-443. (Pubitemid 28232087)
253. Carroll, K. S., Hanna, J., Simon, I., Krise, J., Barbero, P. & Pfeffer, S. R. (2001). Role of Rab9 GTPase in facilitating receptor recruitment by TIP47. Science, 292, 1373-1376. (Pubitemid 32476223)
254. Wolins, N. E., Rubin, B. & Brasaemle, D. L. (2001). TIP47 associates with lipid droplets. J. Biol. Chem. 276, 5101-5108.
255. Miura, S., Gan, J.-W., Brzostowski, J., Parisi, M. J., Schultz, C. J., Londos, C. et al. (2002). Functional conservation for lipid storage droplet association among Perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium. J. Biol. Chem. 277, 32253-32257. (Pubitemid 34969041)
256. Bulankina, A. V., Deggerich, A., Wenzel, D., Mutenda, K., Wittmann, J. G., Rudolph, M. G. et al. (2009). TIP47 functions in the biogenesis of lipid droplets. J. Cell Biol. 185, 641-655.
257. Barbero, P., Buell, E., Zulley, S. & Pfeffer, S. R. (2001). TIP47 is not a component of lipid droplets. J. Biol. Chem. 276, 24348-24351.
258. Bickel, P. E., Tansey, J. T. & Welte, M. A. (2009). PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim. Biophys. Acta, 1791, 419-440.
259. Blot, G., Janvier, K., Le Panse, S., Benarous, R. & Berlioz-Torrent, C. (2003). Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity. J. Virol. 77, 6931-6945. (Pubitemid 36666886)
260. Lopez-Vergès, S., Camus, G., Blot, G., Beauvoir, R., Benarous, R. & Berlioz-Torrent, C. (2006). Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Proc. Natl Acad. Sci. USA, 103, 14947-14952. (Pubitemid 44527834)
261. Bauby, H., Lopez-Vergès, S., Hoeffel, G., Delcroix-Genête, D., Janvier, K., Mammano, F. et al. (2010). TIP47 is required for the production of infectious HIV-1 particles from primary macrophages. Traffic, 11, 455-467.
262. Round, J. L., Tomassian, T., Zhang, M., Patel, V., Schoenberger, S. P. & Miceli, M. C. (2005). Dlgh1 coordinates actin polymerization, synaptic T cell receptor and lipid raft aggregation, and effector function in T cells. J. Exp. Med. 201, 419-430. (Pubitemid 40229416)
263. Blot, V., Delamarre, L., Perugi, F., Pham, D., Bénichou, S., Benarous, R. et al. (2004). Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes. J. Cell Sci. 117, 3983-3993. (Pubitemid 39207334)
264. Perugi, F., Muriaux, D., Ramirez, B. C., Chabani, S., Decroly, E., Darlix, J.-L. et al. (2009). Human Discs Large is a new negative regulator of human immunodeficiency virus-1 infectivity. Mol. Biol. Cell, 20, 498-508.
265. Segrest, J., De Loof, H., Dohlman, J. G., Brouillette, C. G. & Anantharamaiah, G. M. (1990). Amphipathic helix motif: classes and properties. Proteins, 8, 103-117. (Pubitemid 20262536)
266. Srinivas, S. K., Srinivas, R. V., Anantharamaiah, G. M., Compans, R. W. & Segrest, J. P. (1993). Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J. Biol. Chem. 268, 22895-22899. (Pubitemid 23318354)
267. Miller, M. A., Mietzner, T. A., Cloyd, M. W., Robey, W. G. & Montelaro, R. C. (1993). Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res. Hum. Retroviruses, 9, 1057-1066. (Pubitemid 23347339)
268. Tencza, S. B., Mietzner, T. A. & Montelaro, R. C. (1997). Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants. AIDS Res. Hum. Retroviruses, 13, 263-269. (Pubitemid 27076272)
269. Micoli, K. J., Pan, G., Wu, Y., Williams, J. P., Cook, W. J. & McDonald, J. M. (2000). Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. J. Biol. Chem. 275, 1233-1240. (Pubitemid 30051176)
270. Radding, W., Pan, Z. Q., Hunter, E., Johnston, P., Williams, J. P. & McDonald, J. M. (1996). Expression of HIV-1 envelope glycoprotein alters cellular cal-modulin. Biochem. Biophys. Res. Commun. 218, 192-197. (Pubitemid 26034510)
271. Ishikawa, H., Sasaki, M., Noda, S. & Koga, Y. (1998). Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin. J. Virol. 72, 6574-6580. (Pubitemid 28323973)
272. Micoli, K. J., Mamaeva, O., Piller, S. C., Barker, J. L., Pan, G., Hunter, E. & McDonald, J. M. (2006). Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication. Virology, 344, 468-479. (Pubitemid 43049633)
273. Beary, T. P., Tencza, S. B., Mietzner, T. A. & Montelaro, R. C. (1998). Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein. J. Pept. Res. 51, 75-79. (Pubitemid 28065200)
274. Chow, J. Y. H., Jeffries, C. M., Kwan, A. H., Guss, J. M. & Trewhella, J. (2010). Calmodulin disrupts the structure of the HIV-1 MA protein. J. Mol. Biol. 400, 702-714.
275. Ghanam, R. H., Fernandez, T. F., Fledderman, E. L. & Saad, J. S. (2010). Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. J. Biol. Chem. 285, 41911-41920.
276. Tang, C., Loeliger, E., Luncsford, P., Kinde, I., Beckett, D. & Summers, M. F. (2004). Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl Acad. Sci. USA, 101, 517-522. (Pubitemid 38084668)
277. Kim, E. M., Lee, K. H. & Kim, J. W. (1999). The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of alpha-catenin. Mol. Cell, 9, 281-285. (Pubitemid 129555793)
278. Drees, F., Pokutta, S., Yamada, S., Nelson, W. J. & Weis, W. I. (2005). Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell, 123, 903-915. (Pubitemid 41721035)
279. Pokutta, S., Drees, F., Yamada, S., Nelson, W. J. & Weis, W. I. (2008). Biochemical and structural analysis of alpha-catenin in cell-cell contacts. Bio-chem. Soc. Trans. 36, 141-147. (Pubitemid 351570583)
280. Kim, J. T., Kim, E. M., Lee, K. H., Choi, J.-E., Jhun, B. H. & Kim, J. W. (2002). Leucine zipper domain of HIV-1 gp41 interacted specifically with alpha-cate-nin. Biochem. Biophys. Res. Commun. 291, 1239-1244. (Pubitemid 34694322)
281. Zhang, H., Wang, L., Kao, S., Whitehead, I. P., Hart, M. J., Liu, B. et al. (1999). Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. Curr. Biol. 9, 1271-1274. (Pubitemid 29527156)
282. Ridley, A. J. & Hall, A. (1992). The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell, 70, 389-399.
283. Nobes, C. D. & Hall, A. (1995). Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell, 81, 53-62.
284. Hill, C. S., Wynne, J. & Treisman, R. (1995). The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell, 81, 1159-1170.
285. Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R. & Lacal, J. C. (1997). Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev. 11, 463-475. (Pubitemid 27097645)
286. Olson, M. F., Ashworth, A. & Hall, A. (1995). An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science, 269, 1270-1272.
287. Maselko, M., Ward, C. & Pastey, M. (2011). A RhoA-derived peptide inhibits human immunodeficiency virus-1 entry in vitro. Curr. HIV Res. 9, 1-5.
288. Figueroa, C., Taylor, J. & Vojtek, A. B. (2001). Prenylated Rab acceptor protein is a receptor for prenylated small GTPases. J. Biol. Chem. 276, 28219-28225.
289. Hutt, D. M., Da-Silva, L. F., Chang, L. H., Prosser, D. C. & Ngsee,
290. Abdul-Ghani, M., Gougeon, P. Y., Prosser, D. C., Da-Silva, L. F. & Ngsee, J. K. (2001). PRA isoforms are targeted to distinct membrane compartments. J. Biol. Chem. 276, 6225-6233.
291. Martincic, I., Peralta, M. E. & Ngsee, J. K. (1997). Isolation and characterization of a dual prenylated Rab and VAMP2 receptor. J. Biol. Chem. 272, 26991-26998. (Pubitemid 27452653)
292. Evans, D. T., Tillman, K. C. & Desrosiers, R. C. (2002). Envelope glycoprotein cytoplasmic domains from diverse lentiviruses interact with the prenylated Rab acceptor. J. Virol. 76, 327-337. (Pubitemid 33139017)
293. Blancou, P., Evans, D. T. & Desrosiers, R. C. (2005). PRA1 co-localizes with envelope but does not influence primate lentivirus production, infectivity or envelope incorporation. J. Gen. Virol. 86, 1785-1790. (Pubitemid 40766891)
294. Enouf, V., Chwetzoff, S., Trugnan, G. & Cohen, J. (2003). Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1. J. Virol. 77, 7041-7047. (Pubitemid 36666897)
295. Cuadras, M. A., Bordier, B. B., Zambrano, J. L., Ludert, J. E. & Greenberg, H. B. (2006). Dissecting rotavirus particle-raft interaction with small interfering RNAs: insights into rotavirus transit through the secretory pathway. J. Virol. 80, 3935-3946.
296. Liu, H.-P., Wu, C.-C. & Chang, Y.-S. (2006). PRA1 promotes the intracellular trafficking and NF-kap-paB signaling of EBV latent membrane protein 1. EMBO J. 25, 4120-4130. (Pubitemid 44338752)
297. Compton, S. L. & Behrend, E. N. (2006). PRAF1: a Golgi complex transmembrane protein that interacts with viruses. Biochem. Cell Biol. 84, 940-948. (Pubitemid 46450694)
298. Liang, G., Audas, T. E., Li, Y., Cockram, G. P., Dean, J. D., Martyn, A. C. et al. (2006). Luman/CREB3 induces transcription of the endoplasmic reticulum (ER) stress response protein Herp through an ER stress response element. Mol. Cell. Biol. 26, 7999-8010. (Pubitemid 44630999)
299. DenBoer, L. M., Hardy-Smith, P. W., Hogan, M. R., Cockram, G. P., Audas, T. E. & Lu, R. (2005). Luman is capable of binding and activating transcription from the unfolded protein response element. Bio-chem. Biophys. Res. Commun. 331, 113-119. (Pubitemid 40545149)
300. Blot, G., Lopez-Vergès, S., Treand, C., Kubat, N. J., Delcroix-Genête, D., Emiliani, S. et al. (2006). Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR. J. Mol. Biol. 364, 1034-1047. (Pubitemid 44765046)
301. Emerson, V., Holtkotte, D., Pfeiffer, T., Wang, I.-H., Schnölzer, M., Kempf, T. & Bosch, V. (2010). Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycopro-tein. J. Virol. 84, 1355-1365.
302. Mishra, S., Ande, S. R. & Nyomba, B. L. G. (2010). The role of prohibitin in cell signaling. FEBS J. 277, 3937-3946.
303. Merkwirth, C. & Langer, T. (2009). Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim. Biophys. Acta, 1793, 27-32.
304. Morrow I. C. & Parton, R. G. (2005). Flotillins and the PHB domain protein family: rafts, worms and anaesthetics. Traffic 6, 725-740. (Pubitemid 41179406)
305. Kielec, J. M., Valentine, K. G. & Wand, A. J. (2010). A method for solution NMR structural studies of large integral membrane proteins: reverse micelle encapsulation. Biochim. Biophys. Acta, 1798, 150-160.
306. Ubarretxena-Belandia, I. & Stokes, D. L. (2010). Present and future of membrane protein structure determination by electron crystallography. Adv. Protein Chem. Struct. Biol. 81, 33-60.
307. Fujiyoshi, Y. (2011). Structural physiology based on electron crystallography. Protein Sci. [Electronic publication ahead of print].